Abstract
An efficient green synthesis of 3,4-dihydropyrimidin-2-(1H)-ones/thiones (DHPMs) using MgO/ZrO2 as heterogeneous basic catalyst from an aldehyde, β-keto ester and urea/thiourea under solvent-free conditions is described. A variety of aldehydes were studied with β-keto ester and urea/thiourea giving good to excellent yield of corresponding 3,4-dihydropyrimidin-2-(1H)-ones/thiones. This protocol has advantage of excellent yield, reusability, inexpensive and short reaction time at room temperature. The synthesized catalyst can be reused up to 5 consecutive cycles without any decrease in the yield.
Keywords: DHPMs, green synthesis, multicomponent reactions (MCRs), MgO-ZrO2, medicinal chemistry, alkaloids, Biginelli dihydropyrimidinones, Hantzsh type, batzelladine, anticancer drugs
Letters in Organic Chemistry
Title: A One Pot Green Synthesis of 3,4 Dihydropyrimidin-2-(1H)-ones/Thiones Catalyzed By MgO-ZrO2 Under Solvent-Free Conditions
Volume: 9 Issue: 1
Author(s): Manoj B. Gawande, Deepak M. Nagrik and Damodar M. Ambhore
Affiliation:
Keywords: DHPMs, green synthesis, multicomponent reactions (MCRs), MgO-ZrO2, medicinal chemistry, alkaloids, Biginelli dihydropyrimidinones, Hantzsh type, batzelladine, anticancer drugs
Abstract: An efficient green synthesis of 3,4-dihydropyrimidin-2-(1H)-ones/thiones (DHPMs) using MgO/ZrO2 as heterogeneous basic catalyst from an aldehyde, β-keto ester and urea/thiourea under solvent-free conditions is described. A variety of aldehydes were studied with β-keto ester and urea/thiourea giving good to excellent yield of corresponding 3,4-dihydropyrimidin-2-(1H)-ones/thiones. This protocol has advantage of excellent yield, reusability, inexpensive and short reaction time at room temperature. The synthesized catalyst can be reused up to 5 consecutive cycles without any decrease in the yield.
Export Options
About this article
Cite this article as:
B. Gawande Manoj, M. Nagrik Deepak and M. Ambhore Damodar, A One Pot Green Synthesis of 3,4 Dihydropyrimidin-2-(1H)-ones/Thiones Catalyzed By MgO-ZrO2 Under Solvent-Free Conditions, Letters in Organic Chemistry 2012; 9 (1) . https://dx.doi.org/10.2174/157017812799303980
DOI https://dx.doi.org/10.2174/157017812799303980 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pharmacological Manipulation of Brain Glycogenolysis as a Therapeutic Approach to Cerebral Ischemia
Mini-Reviews in Medicinal Chemistry Classification of Normal and Epileptic EEG Signals Using Adaptive Neuro-Fuzzy Network Based on Time Series Prediction
Neuroscience and Biomedical Engineering (Discontinued) Mind-Body Practices and the Adolescent Brain: Clinical Neuroimaging Studies
Adolescent Psychiatry PDZ Domain Protein-Protein Interactions: A Case Study with PICK1
Current Topics in Medicinal Chemistry Anxiolytic-Like Effects of 7H-Benzo[e]perimidin-7-One Derivatives through Elevated Plus-Maze Test in Mice
Current Topics in Medicinal Chemistry The Antiepileptic Potential of Nucleosides
Current Medicinal Chemistry Carnitine Metabolism and Deficit - When Supplementation is Necessary?
Current Pharmaceutical Biotechnology Aldehyde Dehydrogenase as a Marker for Stem Cells
Current Stem Cell Research & Therapy Editorial:Cannabis: Neurological Correlates in Abuse and Medical Use
CNS & Neurological Disorders - Drug Targets Induction of Nuclear Receptors and Drug Resistance in the Brain Microvascular Endothelial Cells Treated with Antiepileptic Drugs
Current Neurovascular Research Editorial
Current Medical Imaging Renin-Angiotensin System in Central Nervous System Diseases and its Interaction with COVID-19
Current Medicinal Chemistry Adeno-Associated Virus (AAV) Vectors in the CNS
Current Gene Therapy Editorial
Current Medical Imaging Targeting TRPs in Neurodegenerative Disorders
Current Topics in Medicinal Chemistry Different Concepts of Drug Delivery in Disease Entities
Mini-Reviews in Medicinal Chemistry Development, Recent Achievements and Current Directions of Research into GABA Uptake Inhibitors
Current Medicinal Chemistry Endoplasmic Reticulum Protein Quality Control in Neurodegenerative Disease: The Good, the Bad and the Therapy
Current Medicinal Chemistry 5'-Nucleotidases, Nucleosides and their Distribution in the Brain: Pathological and Therapeutic Implications
Current Medicinal Chemistry Editorial
Current Medicinal Chemistry